Characterization of the Transmembrane Transport and Absolute Bioavailability of the HCV Protease Inhibitor Danoprevir Publication Characterization of the Transmembrane Transport and Absolute Bioavailability of the HCV Protease Inhibitor Danoprevir Danielle Pillsbury2014 年 12 月 1 日
Pharmacokinetics and Pharmacodynamics of Setrobuvir, an Orally Administered Hepatitis C Virus Non-nucleoside Analog Inhibitor Publication Pharmacokinetics and Pharmacodynamics of Setrobuvir, an Orally Administered Hepatitis C Virus Non-nucleoside Analog Inhibitor Danielle Pillsbury2014 年 12 月 1 日
Meropenem in Children Receiving Continuous Renal Replacement Therapy: Clinical Trial Simulations Using Realistic Covariates Publication Meropenem in Children Receiving Continuous Renal Replacement Therapy: Clinical Trial Simulations Using Realistic Covariates Meropenem is frequently prescribed in children receiving continuous renal replacement therapy (CRRT). Fluid overload is…Danielle Pillsbury2014 年 12 月 1 日
A Pharmacokinetic/Viral Kinetic Model to Evaluate the Treatment Effectiveness of Danoprevir Against Chronic HCV Publication A Pharmacokinetic/Viral Kinetic Model to Evaluate the Treatment Effectiveness of Danoprevir Against Chronic HCV Danielle Pillsbury2014 年 10 月 16 日
Understanding the Effect of the HCV Polymerase Inhibitor Mericitabine on Early Viral Kinetics in the Phase 2 JUMP-C and PROPEL Studies Publication Understanding the Effect of the HCV Polymerase Inhibitor Mericitabine on Early Viral Kinetics in the Phase 2 JUMP-C and PROPEL Studies Danielle Pillsbury2014 年 8 月 21 日
Comparative Benefit of Malaria Chemoprophylaxis Modeled in United Kingdom Travelers Publication Comparative Benefit of Malaria Chemoprophylaxis Modeled in United Kingdom Travelers Danielle Pillsbury2014 年 8 月 5 日
Activities of Ceftazidime and Avibactam Against β-lactamase-producing Enterobacteriaceae in a Hollow-fiber Pharmacodynamic Model Publication Activities of Ceftazidime and Avibactam Against β-lactamase-producing Enterobacteriaceae in a Hollow-fiber Pharmacodynamic Model Avibactam is a novel non-β-lactam β-lactamase inhibitor that is currently undergoing phase 3 clinical trials…Danielle Pillsbury2014 年 6 月 1 日
The Posology of Oseltamivir in Infants with Influenza Infection Using a Population Pharmacokinetic Approach Publication The Posology of Oseltamivir in Infants with Influenza Infection Using a Population Pharmacokinetic Approach Danielle Pillsbury2014 年 5 月 27 日
Population Pharmacokinetics of Azithromycin in Whole Blood, Peripheral Blood Mononuclear Cells, and Polymorphonuclear Cells in Healthy Adults Publication Population Pharmacokinetics of Azithromycin in Whole Blood, Peripheral Blood Mononuclear Cells, and Polymorphonuclear Cells in Healthy Adults Azithromycin's extensive distribution to proinflammatory cells, including peripheral blood mononuclear cells (PBMCs) and polymorphonuclear cells…Danielle Pillsbury2014 年 3 月 5 日
Clinical Population Pharmacokinetics and Toxicodynamics of Linezolid Publication Clinical Population Pharmacokinetics and Toxicodynamics of Linezolid Danielle Pillsbury2014 年 2 月 10 日